313 related articles for article (PubMed ID: 24209986)
1. [Interest of the cholinesterase assay during organophosphate poisonings].
Jalady AM; Dorandeu F
Ann Fr Anesth Reanim; 2013 Dec; 32(12):856-62. PubMed ID: 24209986
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell acetylcholinesterase and plasma butyrylcholinesterase status: important indicators for the treatment of patients poisoned by organophosphorus compounds.
Thiermann H; Kehe K; Steinritz D; Mikler J; Hill I; Zilker T; Eyer P; Worek F
Arh Hig Rada Toksikol; 2007 Sep; 58(3):359-66. PubMed ID: 17913691
[TBL] [Abstract][Full Text] [Related]
3. Activity of cholinesterases in a young and healthy middle-European population: Relevance for toxicology, pharmacology and clinical praxis.
Karasova JZ; Maderycova Z; Tumova M; Jun D; Rehacek V; Kuca K; Misik J
Toxicol Lett; 2017 Aug; 277():24-31. PubMed ID: 28465191
[TBL] [Abstract][Full Text] [Related]
4. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
5. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
[TBL] [Abstract][Full Text] [Related]
6. Effect of different oximes on rat and human cholinesterases inhibited by methamidophos: a comparative in vitro and in silico study.
Lugokenski TH; Gubert P; Bueno DC; Nogara PA; de Aquino Saraiva R; Barcelos RP; Carratu VS; Bresolin L; de Vargas Barbosa NB; Pereira ME; da Rocha JB; Soares FA
Basic Clin Pharmacol Toxicol; 2012 Dec; 111(6):362-70. PubMed ID: 22703537
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
8. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
Antonijevic B; Stojiljkovic MP
Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia.
Reiner E; Radić Z; Simeon-Rudolf V
Arh Hig Rada Toksikol; 2007 Sep; 58(3):329-38. PubMed ID: 17913688
[TBL] [Abstract][Full Text] [Related]
10. Variable response of cholinesterase activities following human exposure to different types of organophosphates.
Moon J; Chun B; Lee S
Hum Exp Toxicol; 2015 Jul; 34(7):698-706. PubMed ID: 25712411
[TBL] [Abstract][Full Text] [Related]
11.
Mohammadi H; Jalilian J; Karimi MY; Shetab-Boushehri SV
Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e293-e300. PubMed ID: 29062551
[TBL] [Abstract][Full Text] [Related]
12. New therapeutic approaches and novel alternatives for organophosphate toxicity.
Katz FS; Pecic S; Schneider L; Zhu Z; Hastings-Robinson A; Luzac M; Macdonald J; Landry DW; Stojanovic MN
Toxicol Lett; 2018 Jul; 291():1-10. PubMed ID: 29614332
[TBL] [Abstract][Full Text] [Related]
13. A case report of cholinesterase inhibitor poisoning: cholinesterase activities and analytical methods for diagnosis and clinical decision making.
Amend N; Langgartner J; Siegert M; Kranawetvogl T; Koller M; John H; Pflügler C; Mögele-Schmid C; Worek F; Thiermann H; Wille T
Arch Toxicol; 2020 Jun; 94(6):2239-2247. PubMed ID: 32303803
[TBL] [Abstract][Full Text] [Related]
14. Blood acetylcholinesterase and butyrylcholinesterase as biomarkers of cholinesterase depression among pesticide handlers.
Strelitz J; Engel LS; Keifer MC
Occup Environ Med; 2014 Dec; 71(12):842-7. PubMed ID: 25189163
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of cholinesterase activity in poisoning with an organophosphate compound: the clinical approach remains essential].
Mégarbane B
Ann Fr Anesth Reanim; 2013 Dec; 32(12):825-6. PubMed ID: 24246657
[No Abstract] [Full Text] [Related]
17. Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design.
Hammond PI; Kern C; Hong F; Kollmeyer TM; Pang YP; Brimijoin S
J Pharmacol Exp Ther; 2003 Oct; 307(1):190-6. PubMed ID: 12893843
[TBL] [Abstract][Full Text] [Related]
18. [Specific features of the anticonvulsant effect of memantine in mice intoxicated with a model organic phosphate].
Iudin MA; Chepur SV; Bykov VN; Kurpiakova AF; Subbotina SN; Nikiforov AS; Ivanov IM
Eksp Klin Farmakol; 2013; 76(2):3-5. PubMed ID: 23631274
[TBL] [Abstract][Full Text] [Related]
19. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
Kalisiak J; Ralph EC; Cashman JR
J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
[TBL] [Abstract][Full Text] [Related]
20. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
